Procedure-related uptake on CXCR4 PET/CT: a frequent pitfall independent of time and anatomical site

Abstract Introduction As a pan-tumor tracer, chemokine receptor 4 (CXCR4)-directed [ 68 Ga]Ga-PentixaFor is frequently utilized in patients with hematological malignancies. We aimed to evaluate the impact of recent surgical and interventional procedures on uptake. Methods Patients undergoing [ 68 Ga]Ga-PentixaFor PET/CT after prior surgical or interventional procedures were analyzed. Uptake at the procedural site was assessed visually and quantitatively (by applying maximum standardized uptake values [SUV max ], target-to-background ratios [TBR]). Quantitative parameters were compared across anatomical region groups (bone, organ, (sub-)cutaneous, muscle). We stratified patients demonstrating uptake in procedural sites into an early (0–30 days) and late group (≥ 31 days between intervention and [ 68 Ga]Ga-PentixaFor PET). In patients with available [ 18 F]FDG PET/CT, quantitative correlation analyses between both radiotracers were also performed. Results Among 425 [ 68 Ga]Ga-PentixaFor PET/CT examinations, 87 prior invasive procedures (20.5%) were identified. In 53 patients allocated to the early group, 29 subjects demonstrated uptake (54.7%), while in the late group, 22 out of 34 subjects revealed tracer accumulation at procedural sites (64.7%). Across the predefined temporal intervals, uptake rates varied numerically but did not differ significantly overall ( p = 0.071). [ 68 Ga]Ga-PentixaFor SUV max (ρ = -0.03, p = 0.807) and TBR (ρ = 0.02, p = 0.876) showed no significant association between time since procedure. On a compartment level, SUV max ( p = 0.482) and TBR ( p = 0.696) revealed no significant differences across investigated anatomical regions. In cases with available [ 18 F]FDG PET (21/51 [41.2%]), quantitative uptake in procedural sites correlated significantly between both radiotracers (SUV max : ρ = 0.55, p = 0.016; TBR: ρ = 0.68, p = 0.001), indicating that different inflammatory signatures at procedural sites may be captured by both radiotracers. Conclusions Post-procedural CXCR4 uptake occurs frequently, with no statistically significant overall association with time since intervention or involved anatomical compartment.

Authors

Institutions

Publication Details

Journal
Annals of Nuclear Medicine
Published
2026-09-05
DOI
https://doi.org/10.1007/s12149-026-02276-z
Primary Topic
Chemokine receptors and signaling
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Procedure-related uptake on CXCR4 PET/CT: a frequent pitfall independent of time and anatomical site

Philipp E. Hartrampf, Sebastian E. Serfling, Rudolf A. Werner, Takahiro Higuchi et al.
Annals of Nuclear Medicine
Chemokine receptors and signaling
article

Procedure-related uptake on CXCR4 PET/CT: a frequent pitfall independent of time and anatomical site

Philipp E. Hartrampf, Sebastian E. Serfling, Rudolf A. Werner, Takahiro Higuchi, Andreas K. Buck, Yingjun Zhi
article en

Abstract

Abstract Introduction As a pan-tumor tracer, chemokine receptor 4 (CXCR4)-directed [ 68 Ga]Ga-PentixaFor is frequently utilized in patients with hematological malignancies. We aimed to evaluate the impact of recent surgical and interventional procedures on uptake. Methods Patients undergoing [ 68 Ga]Ga-PentixaFor PET/CT after prior surgical or interventional procedures were analyzed. Uptake at the procedural site was assessed visually and quantitatively (by applying maximum standardized uptake values [SUV max ], target-to-background ratios [TBR]). Quantitative parameters were compared across anatomical region groups (bone, organ, (sub-)cutaneous, muscle). We stratified patients demonstrating uptake in procedural sites into an early (0–30 days) and late group (≥ 31 days between intervention and [ 68 Ga]Ga-PentixaFor PET). In patients with available [ 18 F]FDG PET/CT, quantitative correlation analyses between both radiotracers were also performed. Results Among 425 [ 68 Ga]Ga-PentixaFor PET/CT examinations, 87 prior invasive procedures (20.5%) were identified. In 53 patients allocated to the early group, 29 subjects demonstrated uptake (54.7%), while in the late group, 22 out of 34 subjects revealed tracer accumulation at procedural sites (64.7%). Across the predefined temporal intervals, uptake rates varied numerically but did not differ significantly overall ( p = 0.071). [ 68 Ga]Ga-PentixaFor SUV max (ρ = -0.03, p = 0.807) and TBR (ρ = 0.02, p = 0.876) showed no significant association between time since procedure. On a compartment level, SUV max ( p = 0.482) and TBR ( p = 0.696) revealed no significant differences across investigated anatomical regions. In cases with available [ 18 F]FDG PET (21/51 [41.2%]), quantitative uptake in procedural sites correlated significantly between both radiotracers (SUV max : ρ = 0.55, p = 0.016; TBR: ρ = 0.68, p = 0.001), indicating that different inflammatory signatures at procedural sites may be captured by both radiotracers. Conclusions Post-procedural CXCR4 uptake occurs frequently, with no statistically significant overall association with time since intervention or involved anatomical compartment.

Annals of Nuclear Medicine
Johns Hopkins University (US), Johns Hopkins Medicine (US), LMU Klinikum (DE), Universitätsklinikum Würzburg (DE), Ludwig-Maximilians-Universität München (DE)
Deutsche Forschungsgemeinschaft, Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 35%
Chemokine receptors and signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.